MMedication Read More What are transdermal patches?2 August 2025 Imagine if you could wear a patch on your arm and say goodbye to pill-swallowing troubles or the…
MMedication Read More Common allergy medication’s risks outweigh its usefulness, experts say2 August 2025 AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…
NNutrition Read More Smart Bodybuilders in 2025 Use Legal Steroid Alternatives from CrazyBulk for Muscle Growth and Cutting26 July 2025 CrazyBulk CrazyBulk New York City, NY, July 24, 2025 (GLOBE NEWSWIRE) — Feedback from a recent survey shows…
MMedication Read More MHRA Approves UK’s First Nasal Spray for Anaphylaxis21 July 2025 An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare…
MMental health Read More New Clozapine Consensus Guidelines Drop ANC Monitoring15 July 2025 Monitoring absolute neutrophil count (ANC) levels beyond 2 years of clozapine treatment is no longer necessary, new international…
MMedication Read More More Days, More Resistance: Time to Rethink Antibiotics1 July 2025 “One of the most universally accepted beliefs around the world,” said Brad Spellberg, MD, chief medical officer at…
NNutrition Read More Are Pre-Workout Powders Overloading the Heart?19 June 2025 Pre-workout supplements are gaining popularity in Brazil because of their promising effects, including increased focus, energy, endurance, enhanced…
MMedication Read More This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?17 June 2025 This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It? originally appeared on Parade. I…
MMedication Read More Ozempic Face? Woman Says It Made Her Look 10 Years Younger24 May 2025 Quick Read Summary is AI generated, newsroom reviewed. Ozempic, a popular weight loss medication, is widely discussed online.…
MMedication Read More GLP-1 RAs in Eating Disorders: Promising or Perilous?25 April 2025 Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) continue to skyrocket in popularity as both approved and off-label treatments…